UnicoCell Biomed Co's gross profit for the
three
months ended in Dec. 2024 was NT$7.52 Mil. UnicoCell Biomed Co's gross profit for the trailing twelve months (TTM) ended in Dec. 2024 was NT$20.57 Mil.
UnicoCell Biomed Co had a gross margin of 69.43% for the quarter that ended in Dec. 2024 => Durable competitive advantage
During the past 8 years, the highestGross Margin % of UnicoCell Biomed Co was 82.68%. The lowest was 56.93%. And the median was 72.05%.
Warning Sign:
UnicoCell Biomed Co Ltd gross margin has been in long-term decline. The average rate of decline per year is -1.7%.
UnicoCell Biomed Co Gross Profit Historical Data
The historical data trend for UnicoCell Biomed Co's Gross Profit can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of UnicoCell Biomed Co's Gross Profit
For the Biotechnology subindustry, UnicoCell Biomed Co's Gross Profit, along with its competitors' market caps and Gross Profit data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
UnicoCell Biomed Co's Gross Profit Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, UnicoCell Biomed Co's Gross Profit distribution charts can be found below:
* The bar in red indicates where UnicoCell Biomed Co's Gross Profit falls into.
Gross Profit for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$20.57 Mil.
Gross Profit is the numerator in the calculation of Gross Margin.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
UnicoCell Biomed Co (TPE:6794) Gross Profit Explanation
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
UnicoCell Biomed Co had a gross margin of 69.43% for the quarter that ended in Dec. 2024 => Durable competitive advantage
UnicoCell Biomed Co Gross Profit Related Terms
Thank you for viewing the detailed overview of UnicoCell Biomed Co's Gross Profit provided by GuruFocus.com. Please click on the following links to see related term pages.
UnicoCell Biomed Co Ltd is a biotechnology company. Its main business includes new drug R&D and human tissue-derived stem cell inspection and testing, extraction, storage, and technology R&D.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
TPE:6794 has been successfully added to your 